Proteasome blockade exerts an antifibrotic activity by coordinately down‐regulating type I collagen and tissue inhibitor of metalloproteinase‐1 and up‐regulating metalloproteinase‐1 production in human dermal fibroblasts-Reference-Cited by-同舟云学术

Proteasome blockade exerts an antifibrotic activity by coordinately down‐regulating type I collagen and tissue inhibitor of metalloproteinase‐1 and up‐regulating metalloproteinase‐1 production in human dermal fibroblasts

Published:2006-01-12 Issue:3 Volume:20 Page:562-564
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Fineschi Serena¹,Reith Walter²,Guerne Pierre André³,Dayer Jean‐Michel¹,Chizzolini Carlo¹

Affiliation:

1. Immunology and Allergy, Department of Internal MedicineGeneva University HospitalGeneva School of Medicine Geneva Switzerland

2. Department of Pathology and ImmunologyGeneva University HospitalGeneva School of Medicine Geneva Switzerland

3. Rheumatology, Department of Internal MedicineGeneva University HospitalGeneva School of Medicine Geneva Switzerland

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.05-4870fje

Reference50 articles.

1. Pathogenesis of fibrosis: type 1 collagen and the skin

2. Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis

3. Factors Involved in the Regulation of Type I Collagen Gene Expression: Implication in Fibrosis

4. Transcriptional activation of the α1(1) procollagen gene in systemic sclerosis dermal fibroblasts. Role of intronic sequences

5. Identification of elements in the promoter region of the ?1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Light chain deposition disease: pathogenesis, clinical characteristics and treatment strategies;Annals of Hematology;2024-08-28

2. Transforming growth factor-β and matrix metalloproteinases as potential biomarkers of fibrotic lesions induced by tuberculosis: a systematic review and meta-analysis;BMJ Open;2023-10

3. Reviewing the Regulators of COL1A1;International Journal of Molecular Sciences;2023-06-11

4. Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis;Biomedicines;2022-09-01

5. Aryl hydrocarbon receptor signaling activation in systemic sclerosis attenuates collagen production and is a potential antifibrotic target;International Immunopharmacology;2020-11